High Yield, EM Most Vulnerable To Asset Collapse: TCW's Rivelle

High Yield, EM Most Vulnerable To Asset Collapse: TCW's Rivelle

Tad Rivelle, Chief Investment Officer for Fixed Income at TCW Group, on the disconnect between asset prices and income, and current investment strategy. Tom Russo, Managing Partner at Gardner Russo & Gardner LLC, on why Philip Morris is poised to benefit from investment in smoke-free products. Brandon Kochkodin, Managing Editor for Bloomberg News, on how Apple and other big companies are no longer disclosing offshore cash positions, making it difficult to gauge whether tax changes are stoking federal investment.Sandy Miller, Partner at Institutional Venture Partners (IVP) on why Silicon Valley will see IPOs as well as more M&A, and how tech companies have been shutting out Wall Street.

See omnystudio.com/listener for privacy information.

Jaksot(3325)

John Sculley Sees $10 Billion in Revenues for RxAdvance (Audio)

John Sculley Sees $10 Billion in Revenues for RxAdvance (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Former Apple and Pepsi CEO John Sculley on his current entrepreneurial endeavors in healthcare, and the strategies outlined in his n...

12 Heinä 201611min

Pemberton's Durcikova: Investing in Toronto Real Estate (Audio)

Pemberton's Durcikova: Investing in Toronto Real Estate (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Mariana Durcikova, Broker at Pemberton Group, on the benefits to investing in Toronto real estate, compared to NYC.See omnystudio.co...

12 Heinä 201611min

Shire's Ornskov on $1 Billion Potential for Dry-Eye Drug(Audio)

Shire's Ornskov on $1 Billion Potential for Dry-Eye Drug(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Shire CEO Flemming Ornskov on the outlook for the company after getting FDA approval for Xiidra drops to treat dry-eye disease.See o...

12 Heinä 20168min

Gong.io's Bendov on Pioneering Intelligence Sales Tool (Audio)

Gong.io's Bendov on Pioneering Intelligence Sales Tool (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Amit Bendov, CEO and Co-Founder Gong.io, will discuss his new sales intelligence tool, the evolution of artificial intelligence, and...

12 Heinä 20168min

Columbia's Davis on Finding Quality Dividend Stocks (Audio)

Columbia's Davis on Finding Quality Dividend Stocks (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Scott Davis, Senior Portfolio Manager and Head of Income Strategies at Columbia Threadneedle Investments, on investing for income in...

12 Heinä 201611min

Jefferies' Rubel Likes Boeing Long Term: Well Positioned(Audio)

Jefferies' Rubel Likes Boeing Long Term: Well Positioned(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Howard Rubel, Senior Equity Research Analyst of Aerospace & Defense Electronics at Jefferies LLC, with an overview of the aerospace ...

12 Heinä 201611min

EnChroma's Schmeder on Bringing Color to the Colorblind (Audio)

EnChroma's Schmeder on Bringing Color to the Colorblind (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Andy Schmeder, CEO and Co-Founder of EnChroma, on their eyeglass technology that helps colorblind people see color.See omnystudio.co...

11 Heinä 20168min

Bloomberg's Hutton on New UK Prime Minister Theresa May (Audio)

Bloomberg's Hutton on New UK Prime Minister Theresa May (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Rob Hutton, UK government and politics reporter for Bloomberg, on Home Secretary Theresa May to succeed David Cameron as the UK prim...

11 Heinä 201611min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
ostan-asuntoja-podcast
rss-rahamania
inderespodi
herrasmieshakkerit
pomojen-suusta
rss-h-asselmoilanen
rss-paasipodi
taloudellinen-mielenrauha
sijoituspodi
rss-bisnesta-bebeja
syo-nuku-saasta
rahapuhetta
asuntoasiaa-paivakirjat
rss-laakispodi
rss-rikasta-elamaa
rss-seuraava-potilas